255 related articles for article (PubMed ID: 6244906)
21. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
Kayanakis JG; Giraud P; Puel J; Cassagneau B; Sabot G; Fauvel JM; Bounhoure JP
Nouv Presse Med; 1981 Apr; 10(19):1583-6. PubMed ID: 6269558
[TBL] [Abstract][Full Text] [Related]
22. Hemodynamic and regional blood flow response to captopril in congestive heart failure.
Levine TB; Olivari MT; Cohn JN
Am J Med; 1984 May; 76(5B):38-42. PubMed ID: 6375361
[TBL] [Abstract][Full Text] [Related]
23. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
Kluger J; Cody RJ; Laragh JH
Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
[TBL] [Abstract][Full Text] [Related]
24. Comparative immediate hemodynamic and hormonal effects of amrinone and captopril in patients with severe chronic heart failure.
Packer M; Medina N; Yushak M
Am J Med Sci; 1986 Jan; 291(1):8-15. PubMed ID: 3510545
[TBL] [Abstract][Full Text] [Related]
25. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme.
Davis R; Ribner HS; Keung E; Sonnenblick EH; LeJemtel TH
N Engl J Med; 1979 Jul; 301(3):117-21. PubMed ID: 221810
[TBL] [Abstract][Full Text] [Related]
26. Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure.
Levine TB; Cohn JN
Am Heart J; 1982 Nov; 104(5 Pt 2):1159-64. PubMed ID: 6182784
[TBL] [Abstract][Full Text] [Related]
27. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
Topic N; Kramer B; Massie B
Am Heart J; 1982 Nov; 104(5 Pt 2):1172-9. PubMed ID: 6291362
[TBL] [Abstract][Full Text] [Related]
28. Combined vasodilator therapy for chronic congestive heart failure.
Cody RJ; Franklin KW; Laragh JH
Am Heart J; 1983 Apr; 105(4):575-80. PubMed ID: 6340448
[TBL] [Abstract][Full Text] [Related]
29. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Turini GA; Waeber B; Brunner HR
Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
[TBL] [Abstract][Full Text] [Related]
30. Vasodilator therapy of severe congestive heart failure: the special importance of angiotensin-converting enzyme inhibition with captopril.
Awan NA; Mason DT
Am Heart J; 1982 Nov; 104(5 Pt 2):1127-36. PubMed ID: 6291358
[TBL] [Abstract][Full Text] [Related]
31. Long-term hemodynamic and clinical efficacy of captopril therapy in ambulatory management of severe chronic congestive heart failure.
Awan NA; Amsterdam EA; Hermanovich J; Bommer WJ; Needham KE; Mason DT
Am Heart J; 1982 Apr; 103(4 Pt 1):474-9. PubMed ID: 6801943
[TBL] [Abstract][Full Text] [Related]
32. Captopril in refractory heart failure: clinical and hemodynamic observations.
Abinader EG; Sharif D; Rosenfeld T; Malouf S
Cardiology; 1983; 70(6):326-32. PubMed ID: 6370433
[TBL] [Abstract][Full Text] [Related]
33. [Precapillary pulmonary hypertension: effect of Captopril].
Sanguinetti M; Galiè N; Magelli C; Orselli L; Magnani B
G Ital Cardiol; 1982; 12(6):436-41. PubMed ID: 6761221
[TBL] [Abstract][Full Text] [Related]
34. Effects of converting enzyme inhibitor on hepatic blood flow in man.
Crossley IR; Bihari D; Gimson AE; Westaby D; Richardson PJ; Williams R
Am J Med; 1984 May; 76(5B):62-5. PubMed ID: 6328986
[TBL] [Abstract][Full Text] [Related]
35. Hemodynamic effects of captropril in chronic heart failure: efficacy of low-dose treatment and comparison with prazosin.
Sharpe DN; Coxon R
Am Heart J; 1982 Nov; 104(5 Pt 2):1164-71. PubMed ID: 6291361
[TBL] [Abstract][Full Text] [Related]
36. Acute and long-term effects of captopril on left and right ventricular volumes and function in chronic heart failure.
Massie BM; Kramer BL; Topic N
Am Heart J; 1982 Nov; 104(5 Pt 2):1197-203. PubMed ID: 6291366
[TBL] [Abstract][Full Text] [Related]
37. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK
N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425
[TBL] [Abstract][Full Text] [Related]
38. Captopril or nifedipine? Comparison of rest and exercise acute effects and long-term therapy in chronic isolated asymptomatic moderate to severe aortic regurgitation.
Banaszewski M; Rydlewska-Sadowska W; Rubkiewicz S
J Heart Valve Dis; 1998 Sep; 7(5):488-99. PubMed ID: 9793844
[TBL] [Abstract][Full Text] [Related]
39. Variable clinical response to long-term angiotensin inhibition in severe heart failure: demonstration of additive benefits of alpha-receptor blockade.
Kugler J; Maskin CS; Frishman W; Sonnenblick EH; LeJemtel TH
Am Heart J; 1982 Nov; 104(5 Pt 2):1154-9. PubMed ID: 6127943
[TBL] [Abstract][Full Text] [Related]
40. Haemodynamic and myocardial metabolic effects of captopril in chronic heart failure.
Chatterjee K; Rouleau JL; Parmley WW
Br Heart J; 1982 Mar; 47(3):233-8. PubMed ID: 7037025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
